M&T Bank Corp Invitae Corp Transaction History

M&T Bank Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$33.06 - $56.93 $280,249 - $482,595	-8,477 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$39.09 - $57.4 $1,954 - $2,870	-50 Reduced 0.59%	8,477 $354,000
Q3 2020 Nov 06, 2020	SELL	$28.43 - $44.67 $112,270 - $176,401	-3,949 Reduced 31.65%	8,527 $370,000
Q2 2020 Jul 29, 2020	BUY	$11.71 - $30.29 $146,093 - $377,898	12,476 New	12,476 $378,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.